CLSA Events

Executive Series: Aspiring Giants: How Emerging Pharmas Can Grow to $1 Billion—and Beyond

In collaboration withPWC

Amid the volatile blend of opportunity and challenge that characterize the global pharmaceutical industry, only a few small companies have managed to catapult their revenue over the $1 billion mark over the past two decades. Whether they chose to expand their therapeutic area focus and product portfolios, enter new geographies, or grow their core business, these aspiring giants pursued three distinct strategies to jump-start growth:

  • Leveraging core product / technology capabilities to launch differentiated products
  • Using mergers & acquisitions to gain new products and/or expand geographic presence
  • Building a strong, stable leadership team armed with a compelling vision and relentless drive

Join us to explore these topics and discuss their applicability to growing the next generation of leading companies, given the rapidly changing healthcare landscape.


Dinkar Saran
Partner, PwC

Jennifer Parkhurst
Partner, PwC

What: Aspiring Giants: How Emerging Pharmas
Can Grow to $1 Billion—and Beyond
When: Tuesday, September 18, 2012
5:30PM – 7:00PM
Where: Theravance
901 Gateway Blvd.
South San Francisco, CA, 94080
Parking: Complimentary On-Site
Attire: Business attire suggested
Attendance: RSVP by September 17th is required
No on-site registrations accepted

Open to C-Suite Executives of
Life Sciences Companies Only.
Cost: BayBio Members – FREE
Non-Members – $75.00